Denali Therapeutics Inc.
DNLI
$13.15
$0.413.22%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -19.54% | -24.58% | -24.76% | -27.29% | -22.58% |
| Total Receivables | -36.52% | -33.33% | -58.82% | -40.63% | -63.15% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 14.23% | -2.06% | 4.26% | 3.87% | -2.30% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -18.77% | -23.98% | -24.16% | -26.53% | -22.46% |
|
|
|||||
| Total Current Assets | -18.77% | -23.98% | -24.16% | -26.53% | -22.46% |
| Net Property, Plant & Equipment | 75.37% | 51.27% | 7.99% | 2.86% | -3.87% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -46.31% | 137.83% | 250.41% | 218.36% | 35.41% |
| Total Assets | 19.09% | 17.56% | 15.07% | 12.19% | -20.98% |
|
|
|||||
| Total Accounts Payable | 17.44% | 711.68% | 63.57% | 435.21% | 239.89% |
| Total Accrued Expenses | 5.99% | 0.97% | -7.89% | -39.65% | 3.14% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 65.76% | 15.30% | 14.72% | 14.88% | -0.79% |
| Total Finance Division Other Current Liabilities | -- | 57.13% | 30.83% | -95.81% | -- |
| Total Other Current Liabilities | -- | 57.13% | 30.83% | -95.81% | -- |
| Total Current Liabilities | 31.07% | 22.36% | 7.46% | -78.88% | -78.57% |
|
|
|||||
| Total Current Liabilities | 31.07% | 22.36% | 7.46% | -78.88% | -78.57% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -5.99% | -5.13% | -15.94% | -14.86% | -15.18% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | 940.63% | -- | -- | -- |
| Total Liabilities | 17.51% | 14.41% | -2.86% | -71.62% | -70.57% |
|
|
|||||
| Common Stock & APIC | 28.89% | 29.37% | 29.78% | 30.48% | 6.25% |
| Retained Earnings | -37.88% | -42.89% | -46.76% | -12.70% | -14.96% |
| Treasury Stock & Other | 214.15% | 949.31% | -84.52% | 48.51% | 109.34% |
| Total Common Equity | 19.28% | 17.90% | 16.87% | 50.56% | -1.10% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 19.28% | 17.90% | 16.87% | 50.56% | -1.10% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 19.28% | 17.90% | 16.87% | 50.56% | -1.10% |
|
|
|||||